GLP-3

Metabolic Research · 10 mg fill · Research Peptide

A triple GIP, GLP-1 and glucagon receptor agonist for incretin research.

Overview

GLP-3 is an investigational synthetic peptide studied as a triple agonist at the GIP, GLP-1 and glucagon receptors. It is not approved by any regulatory agency for any indication. Supplied lyophilized for in-vitro research use.

Specifications

Composition

Triple GIP/GLP-1/glucagon receptor agonist (investigational, lipidated peptide)

Form

Lyophilized powder

Vial Size

10 mg

Reconstitution

Bacteriostatic water

Storage

Room temperature · protect from light

Research use

• Triple-agonist receptor-binding assays
• GCGR, GIPR and GLP-1R signaling comparison
• Structural and receptor-conformation studies
• Comparative incretin-analog research

For research use only. This product is intended for laboratory and educational research purposes only. It is not made, labelled or sold as a drug, supplement or medical device, and it is not for human or veterinary consumption, diagnosis, treatment or cure of any condition. No dosing information is provided or implied. The molecule in this product is also the medicinal ingredient of a drug that has been authorized, or is under clinical investigation, in Canada or the United States; this product is not that drug, carries no drug identification number or marketing authorization, and is supplied solely for in vitro research.

Opens it in the catalog so you can add it to your order.